Middletown, DE -- (SBWIRE) -- 09/26/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Viacom, Inc. (NASDAQ:VIAB), Autodesk, Inc.(NASDAQ:ADSK), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Yandex NV(NASDAQ:YNDX)
Viacom, Inc. (NASDAQ:VIAB) gained volume of 2.87 million shares and the average volume of the stock remained 3.17 million shares. The 52 week range of the stock remained $47.61 - $84.60 and the day range was $82.82 - $83.84.The stock opened the session at $83.70, and closed the session at $82.94. The stock showed a negative performance of -0.53% in previous trading session. Viacom Inc. operates as an entertainment content company in the United States and internationally. The company connects with audiences through compelling content on television, motion picture, online, and mobile platforms. It operates in two segments, Media Networks and Filmed Entertainment.
Has VIAB Found The Bottom and Ready To Move Up? Find Out Here
In previous session, Autodesk, Inc.(NASDAQ:ADSK) traded 2.86 million shares and the average volume of the stock remained 3.35 million shares. The 52 week range of the stock remained $30.20 - $41.72. The stock was a bull and advanced +0.15%, while its closing price stayed at $40.82. The market capitalization of the stock remained 9.08 billion. The half-yearly trend of the stock remained negative -1.38%. Autodesk, Inc. operates as a design software and services company worldwide. Its Platform Solutions and Emerging Business segment offers AutoCAD software, a computer-aided design (CAD) application for professional design, drafting, detailing, and visualization in construction, manufacturing, civil engineering, and process plant design fields; and AutoCAD LT, a professional drafting and detailing software.
For How Long ADSK will fight for Profitability? Read This Trend Analysis report
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) volume of the stock was 2.85 million shares in the most recent session and the average volume remained 2.88 million shares. The stock plunged -1.40% and finished the prior session at the closing price of $74.53. The stock traded 2.85 million shares in its previous trading session and its average volume remained 2.88 million shares. Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Its products include telaprevir for the treatment of adults with genotype 1 hepatitis C virus (HCV) infection, Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Cambridge, Massachusetts.
Why Should Investors Buy VRTX After the Recent Fall? Just Go Here and Find Out
Yandex NV(NASDAQ:YNDX) traded with volume of 2.82 million shares and the average volume of the stock remained 2.23 million shares. The stock grew +2.15% and finished the trading at $37.48. The market capitalization of the stock remained 12.32 billion. Yandex N.V. operates an Internet search engine in Russia and internationally. The company offers a range of search, location-based, personalized, and mobile services that enable users to find information, and communicate and connect over the Internet from desktops and mobile devices; and localized homepages for specific geographic markets.
Why Should Investors Buy YNDX After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)